Optimizing immunohistochemistry and multiplex immunofluorescence success with antibody validation

18 May 2021
Optimizing immunohistochemistry and multiplex immunofluorescence success with antibody validation

Watch this presentation by Dr. Mike Spencer, Director of Immunohistochemistry and Digital Pathology at Fortis Life Sciences, titled: Optimizing immunohistochemistry and multiplex immunofluorescence success with antibody validation. This talk was presented at the SelectScience® Virtual Cancer and Immunology Research Summit 2021.

Links